Fig. 1From: Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patientsFluorescein angiographic images of patients with refractory Behcet uveitis. In patient 4, diffuse capillary leakage (a) decreased 6 months after interferon alpha-2a (IFNα2a) therapy (b). In patient 3, moderate vascluitis at the superior arcade (c) was significantly resolved 17 months after the initiation of IFNα2a treatment (d)Back to article page